Haemonetics Corporation HAE
Set alert
At close · Oct 30
After hours · Oct 30, 5:21 PM ET
- YTD
- +49.28%
- 1 year
- +139.35%
- Open
- 120.50
- Prev close
- 119.79
- Mkt cap
- 5.44B
- Vol
- 453.35K
- Avg vol
- 730.90K
- EPS
- 2.07
- P/E
- 57.80
- Div yield
- 0.00%
More statistics
- Low
- 118.40
- High
- 120.47
- Forward P/E
- 20.72
- Beta
- 0.61
- Short ratio
- 4.81
- Inst. own
- 112.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 109.75
- 200-d avg
- 78.42
- 1y target
- 124.50
5D chart
Signals (113)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 3:55 PM | 2 days ago |
| RSI: Overbought | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:35 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:30 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:25 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:25 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:55 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:45 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:45 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:40 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 11:45 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:20 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:15 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:30 AM | 2 days ago |
| RSI: Oversold | Oct 28, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 12:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 10:10 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 27, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:10 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:05 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:45 PM | 4 days ago |
| RSI: Overbought | Oct 27, 12:25 PM | 4 days ago |
| RSI: Overbought | Oct 27, 12:10 PM | 4 days ago |
| RSI: Overbought | Oct 27, 11:45 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 11:50 AM | 5 days ago |
| MACD: Sell Signal | Oct 26, 11:40 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:10 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 11:10 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:55 AM | 5 days ago |
| MACD: Sell Signal | Oct 26, 10:55 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 10:25 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:15 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 26, 9:55 AM | 5 days ago |
| SMA: Bullish | Oct 26, 9:50 AM | 5 days ago |
| SMA: Bearish | Oct 26, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 23, 3:55 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:45 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 3:45 PM | 1 week ago |
| SMA: Bearish | Oct 23, 3:40 PM | 1 week ago |
| RSI: Overbought | Oct 23, 3:25 PM | 1 week ago |
| RSI: Overbought | Oct 23, 3:10 PM | 1 week ago |
| RSI: Overbought | Oct 23, 2:45 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 1:30 PM | 1 week ago |
| SMA: Bullish | Oct 23, 1:20 PM | 1 week ago |
| SMA: Bearish | Oct 23, 1:05 PM | 1 week ago |
| SMA: Bearish | Oct 23, 1:05 PM | 1 week ago |
| SMA: Bullish | Oct 23, 12:45 PM | 1 week ago |
| SMA: Bullish | Oct 23, 12:30 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:20 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:00 PM | 1 week ago |
| SMA: Bullish | Oct 23, 11:10 AM | 1 week ago |
| SMA: Bearish | Oct 23, 10:55 AM | 1 week ago |
| SMA: Bullish | Oct 23, 10:50 AM | 1 week ago |
| SMA: Bearish | Oct 23, 10:25 AM | 1 week ago |
Key statistics
- Market cap
- 5.45B
- Enterprise value
- 6.40B
- Trailing P/E
- 57.83
- Forward P/E
- 20.72
- PEG ratio
- 1.90
- Price / sales
- 4.03
- Price / book
- 6.50
- EPS (TTM)
- 2.07
- Beta
- 0.61
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 7.12%
- Revenue (TTM)
- 1.35B
- Revenue growth
- 5.60%
- Free cash flow
- 312.84M
- Total cash
- 224.52M
- Total debt
- 1.17B
- Return on equity
- 11.20%
- Shares outstanding
- 45.50M
- Short % of float
- 8.82%
- 50-day average
- 109.75
- 200-day average
- 78.42
Analyst view
Consensus: buy
- Target (low)
- 86.00
- Target (mean)
- 124.50
- Target (high)
- 142.00
- Strong buy4
- Buy5
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 1.29.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 27, 2026 | 1.29 | — | — | — |
| Aug 6, 2026 | Jun 27, 2026 | 1.08 | 1.14 | +0.06 | +5.56% |
| May 7, 2026 | Mar 28, 2026 | 1.28 | 1.29 | +0.01 | +0.78% |
| Feb 5, 2026 | Dec 27, 2025 | 1.27 | 1.31 | +0.04 | +3.15% |
| Nov 6, 2025 | Sep 27, 2025 | 1.12 | 1.27 | +0.15 | +13.39% |
| Aug 7, 2025 | Jun 28, 2025 | 1.01 | 1.10 | +0.09 | +8.91% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2026 | Barrington Research | main | Outperform | Outperform |
| Oct 9, 2026 | Mizuho | main | Outperform | Outperform |
| Oct 8, 2026 | BTIG | main | Buy | Buy |
| Sep 17, 2026 | Citigroup | up | Neutral | Buy |
| Sep 3, 2026 | Raymond James | main | Outperform | Outperform |
| Aug 21, 2026 | Baird | main | Outperform | Outperform |
About Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- haemonetics.com
News
- GEHC vs. HAE: Which Stock Is the Better Value Option?
- Ariel Appreciation Fund Q3 2026 Scorecard: Buys, Sells, And Standouts
- All You Need to Know About Haemonetics (HAE) Rating Upgrade to Buy
- Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update
- BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
- 4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch Now
- Haemonetics Receives FDA Approval For PerQseal Elite Vascular Closure System For Large-Bore Arterial Procedures
- Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System
- Haemonetics Gains 149.3% in a Year: What's Driving the Rally?
- Haemonetics (NYSE:HAE) Hits New 52-Week High – Still a Buy?
Your note
Sign in to keep a note on HAE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ABERNATHY ROBERT E | Director | Stock Award(Grant) | Jul 23, 2026 | 27,519 |
| BASIL MICHELLE L | General Counsel | Stock Award(Grant) | May 14, 2026 | 68,829 |
| DARECCA JAMES | Chief Financial Officer | Stock Award(Grant) | May 14, 2026 | 54,444 |
| DOCKENDORFF CHARLES J | Director | Stock Award(Grant) | Jul 23, 2025 | 25,041 |
| GALVIN ROY | Officer | Stock Award(Grant) | May 14, 2026 | 39,882 |
| KROLL MARK W | Director | Stock Award(Grant) | Jul 23, 2026 | 27,295 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.99% | 5,909,258 | 707.33M | Jun 29, 2026 |
| Neuberger Berman Group, LLC | 9.19% | 4,179,443 | 500.28M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.60% | 2,546,394 | 304.80M | Jun 29, 2026 |
| AQR Capital Management, LLC | 4.98% | 2,266,489 | 271.30M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.53% | 2,059,578 | 246.53M | Jun 29, 2026 |
| Ariel Investments, LLC | 4.53% | 2,060,966 | 246.70M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 1,621,301 | 194.07M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 1,441,654 | 172.56M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.62% | 1,194,166 | 142.94M | Sep 29, 2026 |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund | 2.59% | 1,179,168 | 141.15M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 1,041,356 | 124.65M | Jun 29, 2026 |
| Touchstone Strategic TRT-Touchstone Strategic TRT-Touchstone Small Com | 1.35% | 614,824 | 73.59M | Jun 29, 2026 |